nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—ABCB1—melanoma	0.135	1	CbGaD
Quinine—SLC22A5—Dactinomycin—melanoma	0.103	0.171	CbGbCtD
Quinine—CYP1A1—Dacarbazine—melanoma	0.0772	0.128	CbGbCtD
Quinine—CYP2E1—Dacarbazine—melanoma	0.0596	0.0988	CbGbCtD
Quinine—CYP1A2—Carmustine—melanoma	0.0569	0.0943	CbGbCtD
Quinine—CYP1A2—Vemurafenib—melanoma	0.045	0.0745	CbGbCtD
Quinine—CYP3A4—Temozolomide—melanoma	0.043	0.0713	CbGbCtD
Quinine—CYP2D6—Vemurafenib—melanoma	0.0371	0.0614	CbGbCtD
Quinine—CYP1A2—Dacarbazine—melanoma	0.0345	0.0571	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0277	0.0458	CbGbCtD
Quinine—CYP3A7—Docetaxel—melanoma	0.0277	0.0458	CbGbCtD
Quinine—ABCB1—Dactinomycin—melanoma	0.0261	0.0433	CbGbCtD
Quinine—CYP3A4—Vemurafenib—melanoma	0.0236	0.039	CbGbCtD
Quinine—CYP3A5—Docetaxel—melanoma	0.0207	0.0344	CbGbCtD
Quinine—ABCB1—Docetaxel—melanoma	0.0135	0.0224	CbGbCtD
Quinine—CYP3A4—Docetaxel—melanoma	0.00809	0.0134	CbGbCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00065	0.00465	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00065	0.00464	CcSEcCtD
Quinine—Oliguria—Docetaxel—melanoma	0.000649	0.00464	CcSEcCtD
Quinine—Pancytopenia—Bleomycin—melanoma	0.000635	0.00454	CcSEcCtD
Quinine—Ataxia—Carmustine—melanoma	0.000635	0.00454	CcSEcCtD
Quinine—Hearing impaired—Docetaxel—melanoma	0.000628	0.00449	CcSEcCtD
Quinine—Liver function test abnormal—Carmustine—melanoma	0.000624	0.00446	CcSEcCtD
Quinine—Nervous system disorder—Vemurafenib—melanoma	0.000616	0.0044	CcSEcCtD
Quinine—Ataxia—Temozolomide—melanoma	0.000614	0.00439	CcSEcCtD
Quinine—Skin disorder—Vemurafenib—melanoma	0.00061	0.00436	CcSEcCtD
Quinine—Muscular weakness—Carmustine—melanoma	0.000596	0.00426	CcSEcCtD
Quinine—Pancytopenia—Dactinomycin—melanoma	0.000592	0.00423	CcSEcCtD
Quinine—Breast disorder—Temozolomide—melanoma	0.00059	0.00421	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000588	0.0042	CcSEcCtD
Quinine—Hypotension—Vemurafenib—melanoma	0.000587	0.00419	CcSEcCtD
Quinine—Neutropenia—Dactinomycin—melanoma	0.000583	0.00417	CcSEcCtD
Quinine—Muscular weakness—Temozolomide—melanoma	0.000576	0.00411	CcSEcCtD
Quinine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000572	0.00409	CcSEcCtD
Quinine—Pancytopenia—Carmustine—melanoma	0.000554	0.00396	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000551	0.00394	CcSEcCtD
Quinine—Oesophagitis—Docetaxel—melanoma	0.000546	0.0039	CcSEcCtD
Quinine—Neutropenia—Carmustine—melanoma	0.000546	0.0039	CcSEcCtD
Quinine—Decreased appetite—Vemurafenib—melanoma	0.000546	0.0039	CcSEcCtD
Quinine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000542	0.00387	CcSEcCtD
Quinine—Haemoglobin—Bleomycin—melanoma	0.000538	0.00384	CcSEcCtD
Quinine—Pancytopenia—Temozolomide—melanoma	0.000536	0.00383	CcSEcCtD
Quinine—Haemorrhage—Bleomycin—melanoma	0.000535	0.00382	CcSEcCtD
Quinine—Pulmonary oedema—Docetaxel—melanoma	0.000532	0.0038	CcSEcCtD
Quinine—Neutropenia—Temozolomide—melanoma	0.000528	0.00377	CcSEcCtD
Quinine—Agranulocytosis—Dactinomycin—melanoma	0.000519	0.00371	CcSEcCtD
Quinine—Photosensitivity reaction—Temozolomide—melanoma	0.000515	0.00368	CcSEcCtD
Quinine—Renal failure—Carmustine—melanoma	0.000512	0.00366	CcSEcCtD
Quinine—Hepatitis—Dactinomycin—melanoma	0.000499	0.00357	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000499	0.00356	CcSEcCtD
Quinine—Flushing—Bleomycin—melanoma	0.000497	0.00355	CcSEcCtD
Quinine—Body temperature increased—Vemurafenib—melanoma	0.000496	0.00355	CcSEcCtD
Quinine—Deafness—Docetaxel—melanoma	0.000485	0.00347	CcSEcCtD
Quinine—Chills—Bleomycin—melanoma	0.00048	0.00343	CcSEcCtD
Quinine—Erythema multiforme—Dactinomycin—melanoma	0.000472	0.00337	CcSEcCtD
Quinine—Haemoglobin—Carmustine—melanoma	0.00047	0.00336	CcSEcCtD
Quinine—Haemorrhage—Carmustine—melanoma	0.000467	0.00334	CcSEcCtD
Quinine—Erythema—Bleomycin—melanoma	0.000466	0.00333	CcSEcCtD
Quinine—Flushing—Dactinomycin—melanoma	0.000463	0.00331	CcSEcCtD
Quinine—Hypersensitivity—Vemurafenib—melanoma	0.000462	0.0033	CcSEcCtD
Quinine—Visual disturbance—Docetaxel—melanoma	0.000458	0.00327	CcSEcCtD
Quinine—Renal impairment—Docetaxel—melanoma	0.000456	0.00326	CcSEcCtD
Quinine—Dermatitis bullous—Docetaxel—melanoma	0.000454	0.00324	CcSEcCtD
Quinine—Haemoglobin—Temozolomide—melanoma	0.000454	0.00324	CcSEcCtD
Quinine—Hepatitis—Temozolomide—melanoma	0.000452	0.00323	CcSEcCtD
Quinine—Haemorrhage—Temozolomide—melanoma	0.000452	0.00323	CcSEcCtD
Quinine—Asthenia—Vemurafenib—melanoma	0.00045	0.00322	CcSEcCtD
Quinine—Visual impairment—Carmustine—melanoma	0.00045	0.00322	CcSEcCtD
Quinine—Chills—Dactinomycin—melanoma	0.000448	0.0032	CcSEcCtD
Quinine—Urinary tract disorder—Temozolomide—melanoma	0.000446	0.00319	CcSEcCtD
Quinine—Pruritus—Vemurafenib—melanoma	0.000444	0.00317	CcSEcCtD
Quinine—Urethral disorder—Temozolomide—melanoma	0.000443	0.00316	CcSEcCtD
Quinine—Eye disorder—Carmustine—melanoma	0.000437	0.00312	CcSEcCtD
Quinine—Visual impairment—Temozolomide—melanoma	0.000435	0.00311	CcSEcCtD
Quinine—Erythema—Dactinomycin—melanoma	0.000435	0.00311	CcSEcCtD
Quinine—Flushing—Carmustine—melanoma	0.000434	0.0031	CcSEcCtD
Quinine—Diarrhoea—Vemurafenib—melanoma	0.00043	0.00307	CcSEcCtD
Quinine—Erythema multiforme—Temozolomide—melanoma	0.000427	0.00305	CcSEcCtD
Quinine—Eye disorder—Temozolomide—melanoma	0.000422	0.00302	CcSEcCtD
Quinine—Tinnitus—Temozolomide—melanoma	0.000421	0.00301	CcSEcCtD
Quinine—Flushing—Temozolomide—melanoma	0.000419	0.00299	CcSEcCtD
Quinine—Cardiac disorder—Temozolomide—melanoma	0.000419	0.00299	CcSEcCtD
Quinine—Leukopenia—Bleomycin—melanoma	0.000417	0.00298	CcSEcCtD
Quinine—Dizziness—Vemurafenib—melanoma	0.000415	0.00297	CcSEcCtD
Quinine—Mental disorder—Carmustine—melanoma	0.000409	0.00292	CcSEcCtD
Quinine—Ataxia—Docetaxel—melanoma	0.000408	0.00292	CcSEcCtD
Quinine—Immune system disorder—Temozolomide—melanoma	0.000408	0.00291	CcSEcCtD
Quinine—Mediastinal disorder—Temozolomide—melanoma	0.000407	0.00291	CcSEcCtD
Quinine—Erythema—Carmustine—melanoma	0.000407	0.00291	CcSEcCtD
Quinine—Malnutrition—Carmustine—melanoma	0.000407	0.00291	CcSEcCtD
Quinine—Chills—Temozolomide—melanoma	0.000405	0.00289	CcSEcCtD
Quinine—Liver function test abnormal—Docetaxel—melanoma	0.000401	0.00286	CcSEcCtD
Quinine—Vomiting—Vemurafenib—melanoma	0.000399	0.00285	CcSEcCtD
Quinine—Chest pain—Bleomycin—melanoma	0.000397	0.00283	CcSEcCtD
Quinine—Myalgia—Bleomycin—melanoma	0.000397	0.00283	CcSEcCtD
Quinine—Orthostatic hypotension—Docetaxel—melanoma	0.000396	0.00283	CcSEcCtD
Quinine—Abdominal pain upper—Docetaxel—melanoma	0.000396	0.00283	CcSEcCtD
Quinine—Rash—Vemurafenib—melanoma	0.000396	0.00283	CcSEcCtD
Quinine—Mental disorder—Temozolomide—melanoma	0.000396	0.00283	CcSEcCtD
Quinine—Dermatitis—Vemurafenib—melanoma	0.000395	0.00283	CcSEcCtD
Quinine—Headache—Vemurafenib—melanoma	0.000393	0.00281	CcSEcCtD
Quinine—Malnutrition—Temozolomide—melanoma	0.000393	0.00281	CcSEcCtD
Quinine—Erythema—Temozolomide—melanoma	0.000393	0.00281	CcSEcCtD
Quinine—Breast disorder—Docetaxel—melanoma	0.000392	0.0028	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000391	0.00279	CcSEcCtD
Quinine—Leukopenia—Dactinomycin—melanoma	0.000389	0.00278	CcSEcCtD
Quinine—Confusional state—Bleomycin—melanoma	0.000383	0.00274	CcSEcCtD
Quinine—Vision blurred—Carmustine—melanoma	0.000383	0.00274	CcSEcCtD
Quinine—Tremor—Carmustine—melanoma	0.000381	0.00272	CcSEcCtD
Quinine—Oedema—Bleomycin—melanoma	0.00038	0.00272	CcSEcCtD
Quinine—Agitation—Carmustine—melanoma	0.000374	0.00267	CcSEcCtD
Quinine—Nausea—Vemurafenib—melanoma	0.000373	0.00266	CcSEcCtD
Quinine—Thrombocytopenia—Bleomycin—melanoma	0.000372	0.00266	CcSEcCtD
Quinine—Vision blurred—Temozolomide—melanoma	0.00037	0.00265	CcSEcCtD
Quinine—Myalgia—Dactinomycin—melanoma	0.00037	0.00264	CcSEcCtD
Quinine—Bronchospasm—Docetaxel—melanoma	0.000369	0.00264	CcSEcCtD
Quinine—Tremor—Temozolomide—melanoma	0.000368	0.00263	CcSEcCtD
Quinine—Angina pectoris—Docetaxel—melanoma	0.000365	0.00261	CcSEcCtD
Quinine—Leukopenia—Carmustine—melanoma	0.000364	0.0026	CcSEcCtD
Quinine—Anorexia—Bleomycin—melanoma	0.000363	0.00259	CcSEcCtD
Quinine—Agitation—Temozolomide—melanoma	0.000361	0.00258	CcSEcCtD
Quinine—Angioedema—Temozolomide—melanoma	0.000359	0.00257	CcSEcCtD
Quinine—Pancytopenia—Docetaxel—melanoma	0.000356	0.00255	CcSEcCtD
Quinine—Hypotension—Bleomycin—melanoma	0.000355	0.00254	CcSEcCtD
Quinine—Oedema—Dactinomycin—melanoma	0.000355	0.00253	CcSEcCtD
Quinine—Vertigo—Temozolomide—melanoma	0.000353	0.00252	CcSEcCtD
Quinine—Convulsion—Carmustine—melanoma	0.000352	0.00252	CcSEcCtD
Quinine—Leukopenia—Temozolomide—melanoma	0.000352	0.00251	CcSEcCtD
Quinine—Neutropenia—Docetaxel—melanoma	0.000351	0.00251	CcSEcCtD
Quinine—Palpitations—Temozolomide—melanoma	0.000347	0.00248	CcSEcCtD
Quinine—Thrombocytopenia—Dactinomycin—melanoma	0.000347	0.00248	CcSEcCtD
Quinine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000347	0.00248	CcSEcCtD
Quinine—Chest pain—Carmustine—melanoma	0.000346	0.00247	CcSEcCtD
Quinine—Myalgia—Carmustine—melanoma	0.000346	0.00247	CcSEcCtD
Quinine—Convulsion—Temozolomide—melanoma	0.000341	0.00243	CcSEcCtD
Quinine—Dyspnoea—Bleomycin—melanoma	0.000339	0.00242	CcSEcCtD
Quinine—Anorexia—Dactinomycin—melanoma	0.000338	0.00242	CcSEcCtD
Quinine—Confusional state—Carmustine—melanoma	0.000335	0.00239	CcSEcCtD
Quinine—Myalgia—Temozolomide—melanoma	0.000335	0.00239	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000332	0.00237	CcSEcCtD
Quinine—Oedema—Carmustine—melanoma	0.000332	0.00237	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000332	0.00237	CcSEcCtD
Quinine—Decreased appetite—Bleomycin—melanoma	0.000331	0.00236	CcSEcCtD
Quinine—Renal failure—Docetaxel—melanoma	0.000329	0.00235	CcSEcCtD
Quinine—Jaundice—Docetaxel—melanoma	0.000326	0.00233	CcSEcCtD
Quinine—Thrombocytopenia—Carmustine—melanoma	0.000325	0.00232	CcSEcCtD
Quinine—Tachycardia—Carmustine—melanoma	0.000324	0.00231	CcSEcCtD
Quinine—Confusional state—Temozolomide—melanoma	0.000323	0.00231	CcSEcCtD
Quinine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000323	0.00231	CcSEcCtD
Quinine—Oedema—Temozolomide—melanoma	0.000321	0.00229	CcSEcCtD
Quinine—Anorexia—Carmustine—melanoma	0.000316	0.00226	CcSEcCtD
Quinine—Nervous system disorder—Temozolomide—melanoma	0.000315	0.00225	CcSEcCtD
Quinine—Thrombocytopenia—Temozolomide—melanoma	0.000314	0.00224	CcSEcCtD
Quinine—Feeling abnormal—Bleomycin—melanoma	0.000313	0.00224	CcSEcCtD
Quinine—Agranulocytosis—Docetaxel—melanoma	0.000312	0.00223	CcSEcCtD
Quinine—Skin disorder—Temozolomide—melanoma	0.000312	0.00223	CcSEcCtD
Quinine—Hypotension—Carmustine—melanoma	0.00031	0.00222	CcSEcCtD
Quinine—Hyperhidrosis—Temozolomide—melanoma	0.00031	0.00222	CcSEcCtD
Quinine—Decreased appetite—Dactinomycin—melanoma	0.000308	0.0022	CcSEcCtD
Quinine—Anorexia—Temozolomide—melanoma	0.000306	0.00218	CcSEcCtD
Quinine—Musculoskeletal discomfort—Carmustine—melanoma	0.000302	0.00216	CcSEcCtD
Quinine—Urticaria—Bleomycin—melanoma	0.000302	0.00216	CcSEcCtD
Quinine—Haemoglobin—Docetaxel—melanoma	0.000302	0.00216	CcSEcCtD
Quinine—Body temperature increased—Bleomycin—melanoma	0.000301	0.00215	CcSEcCtD
Quinine—Haemorrhage—Docetaxel—melanoma	0.0003	0.00215	CcSEcCtD
Quinine—Hepatitis—Docetaxel—melanoma	0.0003	0.00215	CcSEcCtD
Quinine—Urinary tract disorder—Docetaxel—melanoma	0.000297	0.00212	CcSEcCtD
Quinine—Dyspnoea—Carmustine—melanoma	0.000296	0.00211	CcSEcCtD
Quinine—Urethral disorder—Docetaxel—melanoma	0.000294	0.0021	CcSEcCtD
Quinine—Feeling abnormal—Dactinomycin—melanoma	0.000292	0.00209	CcSEcCtD
Quinine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000292	0.00209	CcSEcCtD
Quinine—Gastrointestinal pain—Dactinomycin—melanoma	0.00029	0.00207	CcSEcCtD
Quinine—Visual impairment—Docetaxel—melanoma	0.000289	0.00207	CcSEcCtD
Quinine—Decreased appetite—Carmustine—melanoma	0.000289	0.00206	CcSEcCtD
Quinine—Gastrointestinal disorder—Carmustine—melanoma	0.000287	0.00205	CcSEcCtD
Quinine—Dyspnoea—Temozolomide—melanoma	0.000286	0.00204	CcSEcCtD
Quinine—Erythema multiforme—Docetaxel—melanoma	0.000284	0.00203	CcSEcCtD
Quinine—Eye disorder—Docetaxel—melanoma	0.000281	0.00201	CcSEcCtD
Quinine—Abdominal pain—Dactinomycin—melanoma	0.00028	0.002	CcSEcCtD
Quinine—Body temperature increased—Dactinomycin—melanoma	0.00028	0.002	CcSEcCtD
Quinine—Hypersensitivity—Bleomycin—melanoma	0.00028	0.002	CcSEcCtD
Quinine—Decreased appetite—Temozolomide—melanoma	0.000279	0.00199	CcSEcCtD
Quinine—Flushing—Docetaxel—melanoma	0.000279	0.00199	CcSEcCtD
Quinine—Cardiac disorder—Docetaxel—melanoma	0.000279	0.00199	CcSEcCtD
Quinine—Gastrointestinal disorder—Temozolomide—melanoma	0.000277	0.00198	CcSEcCtD
Quinine—Feeling abnormal—Carmustine—melanoma	0.000274	0.00195	CcSEcCtD
Quinine—Asthenia—Bleomycin—melanoma	0.000273	0.00195	CcSEcCtD
Quinine—Gastrointestinal pain—Carmustine—melanoma	0.000271	0.00194	CcSEcCtD
Quinine—Immune system disorder—Docetaxel—melanoma	0.000271	0.00194	CcSEcCtD
Quinine—Mediastinal disorder—Docetaxel—melanoma	0.000271	0.00193	CcSEcCtD
Quinine—Chills—Docetaxel—melanoma	0.000269	0.00193	CcSEcCtD
Quinine—Pruritus—Bleomycin—melanoma	0.000269	0.00192	CcSEcCtD
Quinine—Feeling abnormal—Temozolomide—melanoma	0.000264	0.00189	CcSEcCtD
Quinine—Mental disorder—Docetaxel—melanoma	0.000263	0.00188	CcSEcCtD
Quinine—Abdominal pain—Carmustine—melanoma	0.000262	0.00188	CcSEcCtD
Quinine—Body temperature increased—Carmustine—melanoma	0.000262	0.00188	CcSEcCtD
Quinine—Gastrointestinal pain—Temozolomide—melanoma	0.000262	0.00187	CcSEcCtD
Quinine—Erythema—Docetaxel—melanoma	0.000261	0.00187	CcSEcCtD
Quinine—Malnutrition—Docetaxel—melanoma	0.000261	0.00187	CcSEcCtD
Quinine—Hypersensitivity—Dactinomycin—melanoma	0.000261	0.00187	CcSEcCtD
Quinine—Urticaria—Temozolomide—melanoma	0.000255	0.00182	CcSEcCtD
Quinine—Asthenia—Dactinomycin—melanoma	0.000254	0.00182	CcSEcCtD
Quinine—Body temperature increased—Temozolomide—melanoma	0.000254	0.00181	CcSEcCtD
Quinine—Abdominal pain—Temozolomide—melanoma	0.000254	0.00181	CcSEcCtD
Quinine—Hypersensitivity—Carmustine—melanoma	0.000245	0.00175	CcSEcCtD
Quinine—Diarrhoea—Dactinomycin—melanoma	0.000243	0.00173	CcSEcCtD
Quinine—Vomiting—Bleomycin—melanoma	0.000242	0.00173	CcSEcCtD
Quinine—Rash—Bleomycin—melanoma	0.00024	0.00171	CcSEcCtD
Quinine—Dermatitis—Bleomycin—melanoma	0.00024	0.00171	CcSEcCtD
Quinine—Asthenia—Carmustine—melanoma	0.000238	0.0017	CcSEcCtD
Quinine—Hypersensitivity—Temozolomide—melanoma	0.000236	0.00169	CcSEcCtD
Quinine—Syncope—Docetaxel—melanoma	0.000234	0.00167	CcSEcCtD
Quinine—Leukopenia—Docetaxel—melanoma	0.000234	0.00167	CcSEcCtD
Quinine—Palpitations—Docetaxel—melanoma	0.000231	0.00165	CcSEcCtD
Quinine—Asthenia—Temozolomide—melanoma	0.00023	0.00164	CcSEcCtD
Quinine—Loss of consciousness—Docetaxel—melanoma	0.00023	0.00164	CcSEcCtD
Quinine—Diarrhoea—Carmustine—melanoma	0.000227	0.00162	CcSEcCtD
Quinine—Pruritus—Temozolomide—melanoma	0.000227	0.00162	CcSEcCtD
Quinine—Convulsion—Docetaxel—melanoma	0.000226	0.00162	CcSEcCtD
Quinine—Nausea—Bleomycin—melanoma	0.000226	0.00161	CcSEcCtD
Quinine—Vomiting—Dactinomycin—melanoma	0.000226	0.00161	CcSEcCtD
Quinine—Rash—Dactinomycin—melanoma	0.000224	0.0016	CcSEcCtD
Quinine—Chest pain—Docetaxel—melanoma	0.000223	0.00159	CcSEcCtD
Quinine—Myalgia—Docetaxel—melanoma	0.000223	0.00159	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000221	0.00158	CcSEcCtD
Quinine—Dizziness—Carmustine—melanoma	0.00022	0.00157	CcSEcCtD
Quinine—Diarrhoea—Temozolomide—melanoma	0.00022	0.00157	CcSEcCtD
Quinine—Confusional state—Docetaxel—melanoma	0.000215	0.00154	CcSEcCtD
Quinine—Oedema—Docetaxel—melanoma	0.000213	0.00152	CcSEcCtD
Quinine—Dizziness—Temozolomide—melanoma	0.000212	0.00152	CcSEcCtD
Quinine—Vomiting—Carmustine—melanoma	0.000211	0.00151	CcSEcCtD
Quinine—Nausea—Dactinomycin—melanoma	0.000211	0.00151	CcSEcCtD
Quinine—Shock—Docetaxel—melanoma	0.00021	0.0015	CcSEcCtD
Quinine—Rash—Carmustine—melanoma	0.000209	0.0015	CcSEcCtD
Quinine—Nervous system disorder—Docetaxel—melanoma	0.000209	0.00149	CcSEcCtD
Quinine—Dermatitis—Carmustine—melanoma	0.000209	0.00149	CcSEcCtD
Quinine—Thrombocytopenia—Docetaxel—melanoma	0.000209	0.00149	CcSEcCtD
Quinine—Tachycardia—Docetaxel—melanoma	0.000208	0.00149	CcSEcCtD
Quinine—Headache—Carmustine—melanoma	0.000208	0.00149	CcSEcCtD
Quinine—Skin disorder—Docetaxel—melanoma	0.000207	0.00148	CcSEcCtD
Quinine—Vomiting—Temozolomide—melanoma	0.000204	0.00146	CcSEcCtD
Quinine—Anorexia—Docetaxel—melanoma	0.000203	0.00145	CcSEcCtD
Quinine—Rash—Temozolomide—melanoma	0.000202	0.00145	CcSEcCtD
Quinine—Dermatitis—Temozolomide—melanoma	0.000202	0.00144	CcSEcCtD
Quinine—Headache—Temozolomide—melanoma	0.000201	0.00144	CcSEcCtD
Quinine—Hypotension—Docetaxel—melanoma	0.000199	0.00142	CcSEcCtD
Quinine—Nausea—Carmustine—melanoma	0.000197	0.00141	CcSEcCtD
Quinine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000194	0.00139	CcSEcCtD
Quinine—Nausea—Temozolomide—melanoma	0.000191	0.00136	CcSEcCtD
Quinine—Dyspnoea—Docetaxel—melanoma	0.00019	0.00136	CcSEcCtD
Quinine—Decreased appetite—Docetaxel—melanoma	0.000185	0.00133	CcSEcCtD
Quinine—Gastrointestinal disorder—Docetaxel—melanoma	0.000184	0.00132	CcSEcCtD
Quinine—Feeling abnormal—Docetaxel—melanoma	0.000176	0.00126	CcSEcCtD
Quinine—Gastrointestinal pain—Docetaxel—melanoma	0.000174	0.00125	CcSEcCtD
Quinine—Abdominal pain—Docetaxel—melanoma	0.000169	0.0012	CcSEcCtD
Quinine—Body temperature increased—Docetaxel—melanoma	0.000169	0.0012	CcSEcCtD
Quinine—Hypersensitivity—Docetaxel—melanoma	0.000157	0.00112	CcSEcCtD
Quinine—Asthenia—Docetaxel—melanoma	0.000153	0.00109	CcSEcCtD
Quinine—Pruritus—Docetaxel—melanoma	0.000151	0.00108	CcSEcCtD
Quinine—Diarrhoea—Docetaxel—melanoma	0.000146	0.00104	CcSEcCtD
Quinine—Dizziness—Docetaxel—melanoma	0.000141	0.00101	CcSEcCtD
Quinine—Vomiting—Docetaxel—melanoma	0.000136	0.000969	CcSEcCtD
Quinine—Rash—Docetaxel—melanoma	0.000135	0.000961	CcSEcCtD
Quinine—Dermatitis—Docetaxel—melanoma	0.000134	0.00096	CcSEcCtD
Quinine—Headache—Docetaxel—melanoma	0.000134	0.000955	CcSEcCtD
Quinine—Nausea—Docetaxel—melanoma	0.000127	0.000905	CcSEcCtD
Quinine—CHRM2—Signaling Pathways—FGF1—melanoma	6.96e-06	5.74e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ABCB1—melanoma	6.96e-06	5.73e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.93e-06	5.71e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—FASN—melanoma	6.92e-06	5.7e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYP1B1—melanoma	6.92e-06	5.7e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SLC5A5—melanoma	6.87e-06	5.66e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—IL2—melanoma	6.86e-06	5.65e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.84e-06	5.63e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CG—melanoma	6.84e-06	5.63e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—E2F1—melanoma	6.82e-06	5.61e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SLC5A5—melanoma	6.81e-06	5.61e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PRKCA—melanoma	6.79e-06	5.6e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CB—melanoma	6.78e-06	5.59e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PRKCA—melanoma	6.78e-06	5.59e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYP1B1—melanoma	6.75e-06	5.56e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PDGFRA—melanoma	6.74e-06	5.56e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ERCC2—melanoma	6.74e-06	5.55e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ERCC2—melanoma	6.72e-06	5.54e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PRKCA—melanoma	6.68e-06	5.5e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ITGB3—melanoma	6.68e-06	5.5e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GNAQ—melanoma	6.64e-06	5.47e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CD44—melanoma	6.64e-06	5.47e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PPARG—melanoma	6.6e-06	5.44e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GNAQ—melanoma	6.58e-06	5.42e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CD44—melanoma	6.58e-06	5.42e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—SPP1—melanoma	6.55e-06	5.39e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAP2K2—melanoma	6.53e-06	5.38e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PLA2G6—melanoma	6.52e-06	5.37e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCL8—melanoma	6.52e-06	5.37e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CD—melanoma	6.46e-06	5.32e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CD—melanoma	6.45e-06	5.31e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.44e-06	5.31e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PRKCA—melanoma	6.41e-06	5.28e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYP17A1—melanoma	6.4e-06	5.27e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.38e-06	5.26e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ABCB1—melanoma	6.38e-06	5.26e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—ALB—melanoma	6.38e-06	5.25e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—ALB—melanoma	6.37e-06	5.24e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYP1B1—melanoma	6.36e-06	5.24e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ERCC2—melanoma	6.35e-06	5.23e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.31e-06	5.2e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYP1B1—melanoma	6.31e-06	5.2e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.23e-06	5.14e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL2—melanoma	6.23e-06	5.13e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TERT—melanoma	6.21e-06	5.11e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTEN—melanoma	6.2e-06	5.11e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RAC1—melanoma	6.19e-06	5.1e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.1e-06	5.03e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GNA11—melanoma	6.05e-06	4.98e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CD—melanoma	6.01e-06	4.95e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HIF1A—melanoma	5.94e-06	4.89e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—ALB—melanoma	5.93e-06	4.89e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—FASN—melanoma	5.92e-06	4.87e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PRKCA—melanoma	5.87e-06	4.84e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—VCAN—melanoma	5.86e-06	4.82e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ERCC2—melanoma	5.82e-06	4.8e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SLC5A5—melanoma	5.82e-06	4.79e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ABCB1—melanoma	5.7e-06	4.69e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KDR—melanoma	5.68e-06	4.68e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CB—melanoma	5.63e-06	4.64e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GNAQ—melanoma	5.62e-06	4.63e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CD44—melanoma	5.62e-06	4.63e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CB—melanoma	5.62e-06	4.63e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTGS2—melanoma	5.58e-06	4.6e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTGS2—melanoma	5.57e-06	4.59e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.57e-06	4.59e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.5e-06	4.53e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FN1—melanoma	5.46e-06	4.5e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.45e-06	4.49e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYP1B1—melanoma	5.39e-06	4.44e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NOTCH1—melanoma	5.35e-06	4.41e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CG—melanoma	5.32e-06	4.38e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CG—melanoma	5.31e-06	4.37e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.26e-06	4.34e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PRKCA—melanoma	5.24e-06	4.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CD80—melanoma	5.24e-06	4.32e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CB—melanoma	5.24e-06	4.32e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ABCB1—melanoma	5.24e-06	4.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CG—melanoma	5.23e-06	4.31e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KIT—melanoma	5.23e-06	4.31e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—APC—melanoma	5.23e-06	4.31e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—NRAS—melanoma	5.23e-06	4.31e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ERCC2—melanoma	5.2e-06	4.28e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ABCB1—melanoma	5.19e-06	4.28e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTGS2—melanoma	5.19e-06	4.28e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGF—melanoma	5.17e-06	4.26e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PPARG—melanoma	5.14e-06	4.23e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PPARG—melanoma	5.13e-06	4.22e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PRKCA—melanoma	5.12e-06	4.21e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ERCC2—melanoma	5.07e-06	4.18e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CG—melanoma	5.02e-06	4.13e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—MAPK3—melanoma	5.01e-06	4.13e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP17A1—melanoma	4.94e-06	4.07e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—BRAF—melanoma	4.92e-06	4.05e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTEN—melanoma	4.86e-06	4.01e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTEN—melanoma	4.86e-06	4e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PPARG—melanoma	4.84e-06	3.99e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.82e-06	3.97e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PRKCA—melanoma	4.82e-06	3.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IGF1—melanoma	4.79e-06	3.94e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ERCC2—melanoma	4.78e-06	3.94e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PRKCA—melanoma	4.78e-06	3.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—MAPK1—melanoma	4.77e-06	3.93e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—EGFR—melanoma	4.76e-06	3.93e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.76e-06	3.92e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ERCC2—melanoma	4.74e-06	3.91e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CD—melanoma	4.68e-06	3.85e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CD—melanoma	4.67e-06	3.85e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GNA11—melanoma	4.67e-06	3.84e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAP2K1—melanoma	4.63e-06	3.81e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ALB—melanoma	4.62e-06	3.8e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ALB—melanoma	4.61e-06	3.8e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CG—melanoma	4.6e-06	3.79e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CD—melanoma	4.6e-06	3.79e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—FASN—melanoma	4.57e-06	3.76e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	4.55e-06	3.75e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTEN—melanoma	4.53e-06	3.73e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—KRAS—melanoma	4.5e-06	3.71e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC5A5—melanoma	4.49e-06	3.7e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PPARG—melanoma	4.44e-06	3.66e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ABCB1—melanoma	4.44e-06	3.66e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CD—melanoma	4.41e-06	3.63e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FGF2—melanoma	4.4e-06	3.63e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CA—melanoma	4.37e-06	3.6e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ALB—melanoma	4.35e-06	3.59e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GNAQ—melanoma	4.34e-06	3.57e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CD44—melanoma	4.34e-06	3.57e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.31e-06	3.55e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP1B1—melanoma	4.16e-06	3.43e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	4.14e-06	3.41e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MDM2—melanoma	4.12e-06	3.39e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CG—melanoma	4.11e-06	3.38e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PRKCA—melanoma	4.08e-06	3.36e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CB—melanoma	4.08e-06	3.36e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CB—melanoma	4.07e-06	3.35e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ERBB2—melanoma	4.06e-06	3.35e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ERCC2—melanoma	4.05e-06	3.34e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CD—melanoma	4.04e-06	3.33e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTGS2—melanoma	4.04e-06	3.33e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTGS2—melanoma	4.03e-06	3.32e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CG—melanoma	4.01e-06	3.3e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CB—melanoma	4.01e-06	3.3e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ALB—melanoma	3.99e-06	3.29e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PPARG—melanoma	3.96e-06	3.26e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.93e-06	3.23e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PPARG—melanoma	3.87e-06	3.19e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCL8—melanoma	3.85e-06	3.17e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CB—melanoma	3.84e-06	3.17e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—HRAS—melanoma	3.83e-06	3.15e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTGS2—melanoma	3.81e-06	3.14e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CG—melanoma	3.78e-06	3.11e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1B—melanoma	3.76e-06	3.1e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CG—melanoma	3.74e-06	3.08e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AKT1—melanoma	3.72e-06	3.06e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CASP3—melanoma	3.69e-06	3.04e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL2—melanoma	3.68e-06	3.03e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL6—melanoma	3.66e-06	3.02e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PPARG—melanoma	3.64e-06	3e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PPARG—melanoma	3.61e-06	2.98e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CD—melanoma	3.61e-06	2.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CCND1—melanoma	3.59e-06	2.96e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—AKT1—melanoma	3.57e-06	2.94e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ALB—melanoma	3.56e-06	2.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CTNNB1—melanoma	3.55e-06	2.93e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CB—melanoma	3.52e-06	2.9e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTEN—melanoma	3.52e-06	2.9e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CD—melanoma	3.52e-06	2.9e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTEN—melanoma	3.52e-06	2.9e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTGS2—melanoma	3.49e-06	2.88e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MMP9—melanoma	3.48e-06	2.87e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ALB—melanoma	3.48e-06	2.86e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1A—melanoma	3.47e-06	2.86e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTEN—melanoma	3.46e-06	2.85e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NFKB1—melanoma	3.45e-06	2.84e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CA—melanoma	3.43e-06	2.83e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CA—melanoma	3.43e-06	2.82e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ABCB1—melanoma	3.43e-06	2.82e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AKT1—melanoma	3.38e-06	2.78e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.36e-06	2.76e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTEN—melanoma	3.32e-06	2.74e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CD—melanoma	3.32e-06	2.73e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CD—melanoma	3.29e-06	2.71e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ALB—melanoma	3.28e-06	2.7e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ALB—melanoma	3.25e-06	2.68e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CG—melanoma	3.2e-06	2.64e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CA—melanoma	3.19e-06	2.63e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PRKCA—melanoma	3.15e-06	2.6e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CB—melanoma	3.15e-06	2.59e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—VEGFA—melanoma	3.13e-06	2.58e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ERCC2—melanoma	3.13e-06	2.58e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTGS2—melanoma	3.12e-06	2.57e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—STAT3—melanoma	3.1e-06	2.55e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NRAS—melanoma	3.09e-06	2.55e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PPARG—melanoma	3.09e-06	2.54e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CB—melanoma	3.07e-06	2.53e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTEN—melanoma	3.05e-06	2.51e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTGS2—melanoma	3.04e-06	2.51e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK3—melanoma	2.96e-06	2.44e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CB—melanoma	2.89e-06	2.38e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MYC—melanoma	2.88e-06	2.37e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CB—melanoma	2.87e-06	2.36e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTGS2—melanoma	2.87e-06	2.36e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTGS2—melanoma	2.84e-06	2.34e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK1—melanoma	2.82e-06	2.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGFR—melanoma	2.81e-06	2.32e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CD—melanoma	2.81e-06	2.32e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—AKT1—melanoma	2.8e-06	2.31e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—AKT1—melanoma	2.8e-06	2.31e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ALB—melanoma	2.78e-06	2.29e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTEN—melanoma	2.72e-06	2.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KRAS—melanoma	2.66e-06	2.19e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTEN—melanoma	2.65e-06	2.19e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—AKT1—melanoma	2.61e-06	2.15e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTEN—melanoma	2.5e-06	2.06e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CA—melanoma	2.49e-06	2.05e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CA—melanoma	2.48e-06	2.04e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTEN—melanoma	2.48e-06	2.04e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CG—melanoma	2.47e-06	2.03e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CB—melanoma	2.45e-06	2.02e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.44e-06	2.01e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTGS2—melanoma	2.43e-06	2e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PPARG—melanoma	2.38e-06	1.96e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—melanoma	2.36e-06	1.95e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CA—melanoma	2.34e-06	1.93e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HRAS—melanoma	2.26e-06	1.86e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CD—melanoma	2.17e-06	1.79e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL6—melanoma	2.16e-06	1.78e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CA—melanoma	2.15e-06	1.77e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALB—melanoma	2.14e-06	1.77e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTEN—melanoma	2.12e-06	1.75e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—AKT1—melanoma	2.03e-06	1.67e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—AKT1—melanoma	2.03e-06	1.67e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AKT1—melanoma	2e-06	1.64e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CA—melanoma	1.92e-06	1.58e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—AKT1—melanoma	1.91e-06	1.58e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CB—melanoma	1.89e-06	1.56e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTGS2—melanoma	1.87e-06	1.54e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CA—melanoma	1.87e-06	1.54e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CA—melanoma	1.76e-06	1.45e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—AKT1—melanoma	1.76e-06	1.45e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CA—melanoma	1.75e-06	1.44e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTEN—melanoma	1.63e-06	1.35e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—AKT1—melanoma	1.57e-06	1.29e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—AKT1—melanoma	1.53e-06	1.26e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CA—melanoma	1.49e-06	1.23e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—AKT1—melanoma	1.44e-06	1.19e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—AKT1—melanoma	1.43e-06	1.18e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—AKT1—melanoma	1.22e-06	1.01e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CA—melanoma	1.15e-06	9.5e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—AKT1—melanoma	9.42e-07	7.76e-06	CbGpPWpGaD
